Keith Carpenter

Keith Carpenter

Chief Investment Officer at ZYUS LIFE SCIENCES CORPORATION

Net worth: 48 819 $ as of 2024-04-29

Finance
Consumer Services
Process Industries

Profile

Keith Carpenter is currently the Chief Investment & Strategy Officer and Chief Strategy & Investment Officer at ZYUS Life Sciences, Inc. and ZYUS Life Sciences Corp.
respectively.
He previously worked as a Director at ATB Capital Markets, Inc., Managing Director-Equity Research & Agriculture at Canaccord Genuity Corp., and Research Analyst at Canaccord Adams.
He also served as an Independent Non-Executive Director at Fengro Industries Corp.
and Portfolio Manager at Interward Asset Management Ltd.
Mr. Carpenter holds an MBA from Rotman School of Management and an undergraduate degree from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-11-27 125,178 ( 0.18% ) 48 819 $ 2024-04-29

Keith Carpenter active positions

CompaniesPositionStart
ZYUS LIFE SCIENCES CORPORATION Chief Investment Officer 2018-03-31
Chief Investment Officer 2018-07-31
All active positions of Keith Carpenter

Former positions of Keith Carpenter

CompaniesPositionEnd
Analyst-Equity 2017-12-31
Corporate Officer/Principal 2014-12-31
Analyst-Equity 2010-04-21
Portfolio Manager-Equities -
Analyst-Equity 2005-12-30
See the detail of Keith Carpenter's experience

Training of Keith Carpenter

Yale University Undergraduate Degree
Rotman School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Carpenter's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ZYUS LIFE SCIENCES CORPORATION

Energy Minerals

Private companies7

Finance

Finance

Finance

Finance

Finance

Process Industries

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Keith Carpenter
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW